Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-134582
Filing Date
2024-12-09
Accepted
2024-12-09 16:30:51
Documents
7
Effectiveness Date
2024-12-09

Document Format Files

Seq Description Document Type Size
1 S-8 okur_s-8_20241209_no_xbr.htm S-8 144834
2 EX-5.1 okur-ex5_1.htm EX-5.1 22369
3 EX-23.1 okur-ex23_1.htm EX-23.1 4701
4 EX-23.2 okur-ex23_2.htm EX-23.2 4768
5 EX-FILING FEES okur-exfiling_fees.htm EX-FILING FEES 88085
6 GRAPHIC img201043379_0.jpg GRAPHIC 18643
7 GRAPHIC img201043379_1.jpg GRAPHIC 18643
  Complete submission text file 0000950170-24-134582.txt   317555
Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Filer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-283693 | Film No.: 241535494
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)